Cancer


Changes in the kinase expression panel of K562 human leukemia after FWGE treatment 

Results: We have found 16 kinases which expression has temporary or durative (maintained for 24 hour after washing) decreased (e.g.: CCL2, ABR, FLT1, EphB6, TGFa) and 30 which expression has increased (e.g.: CPT1B, IRE1, ITK, RON, LTK, EphB2, FASTK). Conclusions: Our result demonstrated that many of the kinases which expression was altered by FWGE treatment is known to participate in cell cycle, cell migration, apoptosis and signal transduction. Thus, our results might shed light on the main mechanism(s) of action of FWGE and raise the possibility to identify the active substance(es) of this natural extract.

Results: We have found 16 kinases which expression has temporary or durative (maintained for 24 hour after washing) decreased (e.g.: CCL2, ABR, FLT1, EphB6, TGFa) and 30 which expression has increased (e.g.: CPT1B, IRE1, ITK, RON, LTK, EphB2, FASTK). Conclusions: Our result demonstrated that many of the kinases which expression was altered by FWGE treatment is known to participate in cell cycle, cell migration, apoptosis and signal transduction. Thus, our results might shed light on the main mechanism(s) of action of FWGE and raise the possibility to identify the active substance(es) of this natural extract.

Changes in the kinase expression panel of K562 human leukemia after FWGE treatment


1.888.394.3394

1.307.218.9831

Sheridan, Wyoning, USA

www.FWGERX.com

ALL SALES FINAL


*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.


Copyright © 2014 FWGE RX BioSCIENCE - All Rights Reserved.



Share by: